Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer

por Jaworski, Jedrzej J., Morgan, Robert D., Sivakumar, Shivan
Publicado 2020

First-Line Management of Advanced High-Grade Serous Ovarian Cancer

por Mahmood, Reem D., Morgan, Robert D., Edmondson, Richard J., Clamp, Andrew R., Jayson, Gordon C.
Publicado 2020

PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer

por Morgan, Robert D., Clamp, Andrew R., Evans, D. Gareth R., Edmondson, Richard J., Jayson, Gordon C.
Publicado 2018

Multiple-low-dose therapy: effective killing of high-grade serous ovarian cancer cells with ATR and CHK1 inhibitors

por Golder, Anya, Nelson, Louisa, Tighe, Anthony, Barnes, Bethany, Coulson-Gilmer, Camilla, Morgan, Robert D, McGrail, Joanne C, Taylor, Stephen S
Publicado 2022

Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancer

por Morgan, Robert D, Stamatopoulou, Sofia, Mescallado, Nerissa, Saunders, Geoff, Welch, Richard, Mitchell, Claire, Hasan, Jurjees, Clamp, Andrew R, Jayson, Gordon C
Publicado 2019

Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational Status

por Logue, Chloe A., Pugh, Julia, Foden, Philip, Mahmood, Reem D., Morgan, Robert D., Mitchell, Claire, Hasan, Jurjees, Clamp, Andrew R., Jayson, Gordon C.
Publicado 2021

Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes

por Barnes, Bethany M., Nelson, Louisa, Tighe, Anthony, Burghel, George J., Lin, I-Hsuan, Desai, Sudha, McGrail, Joanne C., Morgan, Robert D., Taylor, Stephen S.
Publicado 2021

Exploiting a living biobank to delineate mechanisms underlying disease-specific chromosome instability

por Nelson, Louisa, Barnes, Bethany M., Tighe, Anthony, Littler, Samantha, Coulson-Gilmer, Camilla, Golder, Anya, Desai, Sudha, Morgan, Robert D., McGrail, Joanne C., Taylor, Stephen S.
Publicado 2023

Palliative home parenteral nutrition in patients with ovarian cancer and malignant bowel obstruction: experiences of women and family caregivers

por Sowerbutts, Anne Marie, Lal, Simon, Sremanakova, Jana, Clamp, Andrew R., Jayson, Gordon C., Teubner, Antje, Hardy, Lisa, Todd, Chris, Raftery, Anne-Marie, Sutton, Eileen, Morgan, Robert D., Vickers, Alexander J., Burden, Sorrel
Publicado 2019

c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial

por Morgan, Robert D., Ferreras, Cristina, Peset, Isabel, Avizienyte, Egle, Renehan, Andrew G., Edmondson, Richard J., Murphy, Alexander D., Nicum, Shibani, Van Brussel, Thomas, Clamp, Andrew R., Lambrechts, Diether, Zhou, Cong, Jayson, Gordon C.
Publicado 2022

Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer models

por Coulson-Gilmer, Camilla, Morgan, Robert D., Nelson, Louisa, Barnes, Bethany M., Tighe, Anthony, Wardenaar, René, Spierings, Diana C. J., Schlecht, Helene, Burghel, George J., Foijer, Floris, Desai, Sudha, McGrail, Joanne C., Taylor, Stephen S.
Publicado 2021

DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors

por Pillay, Nisha, Tighe, Anthony, Nelson, Louisa, Littler, Samantha, Coulson-Gilmer, Camilla, Bah, Nourdine, Golder, Anya, Bakker, Bjorn, Spierings, Diana C.J., James, Dominic I., Smith, Kate M., Jordan, Allan M., Morgan, Robert D., Ogilvie, Donald J., Foijer, Floris, Jackson, Dean A., Taylor, Stephen S.
Publicado 2019

Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?

por Morgan, Robert D., Burghel, George J., Flaum, Nicola, Bulman, Michael, Smith, Philip, Clamp, Andrew R., Hasan, Jurjees, Mitchell, Claire L., Salih, Zena, Woodward, Emma R., Lalloo, Fiona, Crosbie, Emma J., Edmondson, Richard J., Schlecht, Helene, Jayson, Gordon C., Evans, D. Gareth R.
Publicado 2023

Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study

por Mahmood, Reem D., Shaw, Danielle, Descamps, Tine, Zhou, Cong, Morgan, Robert D., Mullamitha, Saifee, Saunders, Mark, Mescallado, Nerissa, Backen, Alison, Morris, Karen, Little, Ross A., Cheung, Susan, Watson, Yvonne, O’Connor, James P. B., Jackson, Alan, Parker, Geoff J. M., Dive, Caroline, Jayson, Gordon C.
Publicado 2021

Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles

por Ye, Weiyu, Olsson-Brown, Anna, Watson, Robert A., Cheung, Vincent T. F., Morgan, Robert D., Nassiri, Isar, Cooper, Rosalin, Taylor, Chelsea A., Akbani, Umair, Brain, Oliver, Matin, Rubeta N., Coupe, Nicholas, Middleton, Mark R., Coles, Mark, Sacco, Joseph J., Payne, Miranda J., Fairfax, Benjamin P.
Publicado 2021

A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity

por Nelson, Louisa, Tighe, Anthony, Golder, Anya, Littler, Samantha, Bakker, Bjorn, Moralli, Daniela, Murtuza Baker, Syed, Donaldson, Ian J., Spierings, Diana C. J., Wardenaar, René, Neale, Bethanie, Burghel, George J., Winter-Roach, Brett, Edmondson, Richard, Clamp, Andrew R., Jayson, Gordon C., Desai, Sudha, Green, Catherine M., Hayes, Andy, Foijer, Floris, Morgan, Robert D., Taylor, Stephen S.
Publicado 2020